(1) Suarez Alemán C, Fernández Garcia D, Galán Retamal C, Hevia Álvarez E, López Rubio S, Martín Manzano J, et al. Recomendaciones generales y farmacoterapéuticas para el uso racional de medicamentos en el control glucémico de la diabetes tipo 2. Escuela Andaluza de Salud Pública, editor. Jornadas sobre controversias y consenso en uso racional de medicamentos. Diabetes. Programa de uso racional de medicamentos del Servicio Andaluz de Salud.  10-12. 8. Granada, Escuela Andaluza de Salud Pública.

    (2)   Berengué Iglesias M, Roura Olmeda P. Diabetes Mellitus. In: Sociedad Española de Medicina Familiar y Comunitaria, editor. Guía de actuación en Atención Primaria. 3ª edición ed. Barcelona: SEMFyC editorial; 2006. p. 1100-10.

    (3)   Rose E, Ketchel D. Does daily monitoring of blood glucose predict hemoglobin A1c levels? J Fam Pract 2003;52(6):1-3.

    (4)   Welschen L, Bloemendal E, Nijpels G, Dekker J, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 2005;28(6):1510-7.

(5) NHS. National Institute for Health and Clinical Excellence. Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57). Guidance, 2008.

     (6)   Towfigh A. Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: a meta-analysis. Am J Manag Care 2008;14(7):468-75.

    (7)   Balk E, Teplinsky E, rikalinos T, hew C, hung M, au J, et al. Applicability of the Evidence Regarding Intensive Glycemic Control and Self-Monitored Blood Glucose to Medicare Patients with Type 2 Diabetes REPORT. Maryland: Agency for Healthcare Research and Quality; 2007.

    (8)   Sarmiento Gallego M, Carrillo Ramirez L, España López F, Jarabo López Y. Automedición de la glucemia (AMG): un estudio controlado no aleatorizado. Aten primaria 2007;39(6):326-7.

    (9)   Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Cavalieri D, Di Nardo B, et al. The Impact of Blood Glucose Self-Monitoring on Metabolic Control and Quality of Life in Type 2 Diabetic Patients.An urgent need for better educational strategies. Diabetes Care 2001;24(11):1870-7.

  (10)   Coster S, Guilliford M, Seed P, Powrie J, Swaminathan R. Monitoring blood glucose control in diabetes mellitus: a systematic review. Health Technology Assessment 2000;4(12):31-50.

  (11)   Valcuende Mantilla M. Documentos SEMFyC.Autoanálisis en la diabetes mellitus. Aten primaria 2003;31(6):394-6.

  (12)   Mesa J. Autoanálisis en la diabetes tipo 2: sigue la controversia. Med Clin (Barc) 2006;126(19):742-3.

  (13)   Sánchez-Monfort J, Sánchez-Jover I. Por qué lo llamamos autocontrol cuando deberíamos llamarlo autoanálisis? Aten primaria 2006;37(5):305.

  (14)   Bria Ferre X, Vila Córcoles A. Eficiencia del autocontrol de los pacientes diabéticos tipo 2. FMC 2004;11(5):238-43.

  (15)   Taylor J, Cambpell K. Home Monitoring of Glucose and Blood Pressure. Am Fam Physician 2007;76(2):255-60.

  (16)   Linko L, Lampe K, Ihalainen J, Makela M, Sintonen H. Blood glucose selfmonitoring in diabetes management. Helsinki; 2005. Report No.: 82.

  (17)   National Collaborating Centre for Chronic Conditions. Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). Londres: Royal College of Physicians; 2008.

  (18)   National Institute for Health and Clinical Excellence. Type 2 diabetes.The management of type 2 diabetes. Londres: National Institute for Health and Clinical Excellence; 2008. Report No.: 66.

  (19)   Srinivasan B, Taub N, Khunti K, Davies M. Diabetes: glycaemic control in type 2. BMJ Clinical Evidence 2006;3:609-37.

  (20)   Simon J, Gray A, Clarke P, Wade A, Neil A, Farmer A, et al. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. BMJ 2008.

  (21)   Palmer A, Dinneen S, Gavin J, Gray A, Herman W, Karter A. Costutility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes. Current Medical Research and Opinion 2006;22(5):861-72.

  (22)   American Diabetes Association. Standards of Medical Care in Diabetes—2010. Diabetes Care 2010;33(suppl):S13-S61.

  (23)   Davis W, Bruce D, Davis T. Is Self-Monitoring of Blood Glucose Appropriate for All Type 2 Diabetic Patients? Diabetes Care 2006;29(8):1764-70.

  (24)   Norris S, Engelgau M, Venkat Narayan K. Effectiveness of Self-Management Training in Type 2 Diabetes.A systematic review of randomized controlled trials. Diabetes Care 2001;24(3):561-87.

  (25)   Hirsch I, Bode B, Childs B, Close K, Fisher W, Gavin J, et al. CME Review Paper. Self-Monitoring of Blood Glucose (SMBG) in Insulin- and Non–Insulin-Using Adults with Diabetes: Consensus Recommendations for Improving SMBG Accuracy, Utilization, and Research . Diabetes Technology& Therapeutics 2008;10(6):419-39.

  (26)   Bergenstal R, Gavin JGCCo,  GCCoGMP. The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. Am J Med 2005;118(suppl):S1-S6.

  (27)   Ipp E, Aquino R, Christenson P. Point: Self-Monitoring of Blood Glucose in Type 2 Diabetic Patients not Receiving Insulin. The sanguine approach. Diabetes Care 2005;28(6):1528-30.

  (28)   Nathan D, Buse J, Davidson M, Ferrannini E, Holman R, Sherwin R, et al. Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy. A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32(1):1-11.

  (29)   Norris S, Lau J, Smith S, Shmid C, Engelgau M. Self-Management Education for Adults With Type 2 Diabetes. A meta-analysis of the effect on glycemic control. Diabetes Care 2002;25(7):1159-571.

  (30)   Oria-Pino A, Montero-Perez F, Luna-Morales S, del Campo-Vazquez P, Sánchez-Guijo P. Efectividad y eficacia del autoanálisis de la glucemia capilar en pacientes con diabetes tipo 2. Med Clin (Barc) 2006;126(19):-728.

  (31)   O´Kane M, Bunting B, Copeland M, Coates V, ESMON study group. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 208;336:1174-7.

  (32)   Funnell M, Brown T, Childs B, Haas L, Hosey G, Jensen B, et al. National Standards for Diabetes Self-Management Education. Diabetes Care 2009;31(Suppl 1):S87-S94.

  (33)   Coster S, Seed P. Self-monitoring in type 2 diabetes mellitus: a metaanalysis. Diabet Med 2000;17:755-61.

  (34)   TripAnswer [consultado el 20 de enero de 2009]. For patients with Type 2 diabetes, a) what evidence is there to support the design of an algorithm that will allow those patients to titrate their own insulin and b) what mechanisms are best to evaluate such a design? www Tripdatabase com 2008

  (35)   Parramon M. Particularidades de la medición de la glucemia capilar: aspectos técnicos, clínicos y legales. Endocrinol Nutr 2004;51(7):433-9.

  (36)   Federación Internacional de Diabetes. Guía global para la Diabetes tipo 2. Trend Medical, editor.  13-34. 2005.

  (37)   Ministerio de Sanidad y Consumo (España). Guía de Práctica Clínica en Diabetes tipo 2. Primera ed. Vitoria: Servicio Central de Publicaciones del Gobierno Vasco; 2008.

  (38)   Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007;335(7611):132-40.

  (39)   Saudeck C, Derr L, Kalyani R. Assessing Glycemia in Diabetes Using Self-monitoring Blood Glucose and Hemoglobin A1c. JAMA 2006;295(14):1688-97.

  (40)   Welschen LM. Automonitorización de la glucemia en pacientes con diabetes de tipo 2 que no usan insulina (Revisión Cochrane traducida). Biblioteca Cochrane Plus. 2008. p. 1-24.

  (41)   Scottish Intercollegiate Guidelines Network. Management of Diabetes. A national clinical guideline. Edinburgo: 2001.

  (42)   Regional Drug and Therapeutics Centre. Self-Monitoring of Blood Glucose. Drug Update 50, 1-2. 2007. Newcastle, National Health Service.
Ref Type: Magazine Article

  (43)   Safe Practical clinical Answer (CKS) - Institute for Innovation and Improvement. Diabetes Type 2. Self monitoring of blood glucose. www cks library nhs uk 2009

  (44)   Fernández I, Aguilar D, Amaya M, Barriguete I, Benito P, Conejo M, et al. Diabetes Mellitus 2. Proceso asistencial integrado. Sevilla: 2002.

  (45)   Sarol J. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966 - 2004). Current MedicalResearch and Opinion 2005;21(2):173-83.

  (46)   Jansen J P. Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Current Medical Research and Opinion 2006;22(4):671-81.

  (47)   Institute of Health Economics. Consensus Statement on Self-monitoring in Diabetes. CONSENSUS STATEMENTS 1[1], 4-19. 2006.

  (48)   PREEVID: Preguntas basadas en la Evidencia.Consejeria de Salud de Murcia [consultado el 20 de enero de 2009]. ¿Hasta qué punto los autoanálisis de glucemia mejoran los controles glucémicos y las complicaciones en los diabéticos tipo 2 ? www murciasalud es 2005

  (49)   PREEVID: Preguntas basadas en la Evidencia.Consejeria de Salud de Murcia[ consultado el 20 de enero de 2009]. ¿Cada cuánto tiempo debe un diabético (tipo I y tipo II) hacerse la prueba de glucemia capilar? www murciasalud es 2008

  (50)   PREEVID: Preguntas basadas en la Evidencia.Consejeria de Salud de Murcia [consultado el 20 de enero de 2009]. ¿Existen diferencias en el grado de control glucémico en diabéticos tipo 2 no insulín-dependientes que realizan autocontroles con tiras reactivas respectos a los que no las usan? www murciasalud es 2006

  (51)   TripAnswer [consultado el 20 de enero de 2009]. What evidence is there to support the use of HbA1c and self monitoring of blood glucose for the management of diabetes in primary care? www Tripdatabase com 2008

(52)    Servicio de Farmacia.Distrito Sevilla. Autocontrol con tiras de glucosa: 3 motivos para no recomendar su uso rutinario en diabçeticos no insulinizados.  1-2. 2008. Sevilla, Distrito Sevilla

(53) Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes onthe development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977 -986.

UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet.1998; 352:854 -865.

UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).Lancet . 1998;352:837 -853

Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103-117

Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.N Engl J Med . 2005;353:2643 -2653.

Mensing C, Boucher J, Cypress M, et al. National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-management Education Programs.Diabetes Care 29:S78-S75, 2006.

Saudek CD, Derr RL, Kalyani RR .Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A(1c). JAMA. 295 (14): 1688-1697 , 2006.

Age-adjusted rates of annual dilated-eye exam, daily self-monitoring of blood glucose, foot examination in the last year, and doctor visit for diabetes in the last year per 100 adults with diabetes, United States, 1994-2004. Centers for Disease Control and Prevention Web site. Available at: http://www.cdc.gov/diabetes/statistics/preventive/tx.htm

American Diabetes Association. Test of Glycemia in Diabetes. Position stateman. Diabetes care 2004,27:S91-s93

Ortega Millan C. Novedades en diabetes .AMF 2006;2(3):147-158

National Prescribing Centre. When and how should patients with diabetes mellitus test blood glucose? MeReC Bulletin 2002;13(1):1-4. www.npc.co.uk/MeReC_Bulletins/2002Volumes/vol13no1.pdf (accessed 30 Nov 2007).

Fernandez Fernandez I, Franch Nadal J, Martin Manzano JL, Navarro Perez J, Orozco Beltran D, Vazquez Garijo P. Autoanálisis. en "Programas Basicos de Atencion Primaria: 2. Diabetes. semFYC, 1998

Clua Espuny JL, Puig Junoy J, Ciurana Roca E, García Bernal G, Monclus Benet JF, González Henares A, et al. Auto monitorización de la glucosa sanguínea (MSG): evaluación  de su prescripción  y resultados en la diabetes tipo 2. Aten Primaria 1999;24:316-25

Coster S, Gullifors MC, Seed PT, et al. Self-monitoring in type 2 diabetes mellitus: a meta-analysis.Diabet Med 2000;17:755-61

Mata M, Antonanzas F,Tafalla M,Sanz P. The cost of type 2 diabetes in Spain: the CODE-2 study.Gac Sanit 2002;16(6):511-20

Franciosi M,Pellegrini F,De Berardis G, Belfiglio M,Cavaliere D,Di Nardo B, et al;QuEd Study Group.The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients. Diabetes Care 2001;24(11):1870-7

ADA. Urine Glucose and Ketone Determinations. Position statments. Diabetes Care 1996; 19 (suppl 1): s35.. Online: http://www.diabetes.org/DiabetesCare/Supplement/s35.htm

Canadian Diabetes Association. Recommendations for the use of sel-monitoring of bllod glucose in diabetes mellitus. Position Statements. 1996. Online: http://www.diabetes.ca/prof/csspp001.htm

Campbell LV, Ashwell SM, Borkman M, Chisholm DJ. La hiperglucemia de bata blanca: discrepancias entre glucemia medida en la clínica de diabetes y en el hogar. BMJ (ed. esp) 1992; 24-28.